Free Trial

Bath & Body Works (BBWI) Financials

Bath & Body Works logo
$19.18 +0.78 (+4.26%)
Closing price 03:59 PM Eastern
Extended Trading
$18.84 -0.34 (-1.78%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Bath & Body Works

Annual Income Statements for Bath & Body Works

This table shows Bath & Body Works' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
1,253 1,158 983 644 -366 844 1,333 800 878 798 649
Consolidated Net Income / (Loss)
1,253 1,158 983 644 -366 844 1,333 800 878 798 649
Net Income / (Loss) Continuing Operations
1,253 1,158 983 644 460 865 1,075 794 878 798 649
Total Pre-Tax Income
1,934 1,696 1,312 857 608 1,122 1,423 1,045 1,021 1,028 882
Total Operating Income
2,192 2,003 1,728 1,237 1,040 1,604 2,009 1,376 1,285 1,266 1,126
Total Gross Profit
5,204 5,125 4,959 4,899 2,387 3,096 3,855 3,255 3,236 3,234 3,189
Total Revenue
12,154 12,574 12,632 13,237 5,405 6,434 7,882 7,560 7,429 7,307 7,291
Operating Revenue
12,154 12,574 12,632 13,237 5,405 6,434 7,882 7,560 7,429 7,307 7,291
Total Cost of Revenue
6,950 7,449 7,673 8,338 3,018 3,338 4,027 4,305 4,193 4,073 4,102
Operating Cost of Revenue
6,950 7,449 7,673 8,338 3,018 3,338 4,027 4,305 4,193 4,073 4,102
Total Operating Expenses
3,012 3,122 3,231 3,662 1,347 1,492 1,846 1,879 1,951 1,968 2,063
Selling, General & Admin Expense
3,012 3,122 3,231 3,563 1,347 1,492 1,846 1,879 1,951 1,968 2,063
Total Other Income / (Expense), net
-258 -307 -416 -380 -432 -482 -586 -331 -264 -238 -244
Interest Expense
334 394 406 385 370 432 388 348 345 312 276
Other Income / (Expense), net
76 87 -10 5.00 -62 -50 -198 17 81 74 32
Income Tax Expense
681 538 329 213 148 257 348 251 143 230 233
Basic Earnings per Share
$4.30 $4.04 $3.46 $2.33 ($1.33) $3.04 $4.96 $3.45 $3.86 $3.62 $3.12
Weighted Average Basic Shares Outstanding
287.08M 287M 284M 276M 276.53M 557.63M 238.91M 228.77M 224.90M 214.23M 201.13M
Diluted Earnings per Share
$4.22 $3.98 $3.42 $2.31 ($1.32) $3.00 $4.88 $3.43 $3.84 $3.61 $3.11
Weighted Average Diluted Shares Outstanding
287.08M 287M 284M 276M 276.53M 557.63M 238.91M 228.77M 224.90M 214.23M 201.13M
Weighted Average Basic & Diluted Shares Outstanding
287.08M 287M 284M 276M 276.53M 557.63M 238.91M 228.77M 224.90M 214.23M 201.13M
Cash Dividends to Common per Share
$2.00 $2.40 $2.40 $2.40 $1.20 $0.30 $0.45 $0.80 $0.80 $0.80 $0.80

Quarterly Income Statements for Bath & Body Works

This table shows Bath & Body Works' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/29/2023 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
99 119 579 87 152 106 453 105 64 77 403
Consolidated Net Income / (Loss)
99 119 579 87 152 106 453 105 64 77 403
Net Income / (Loss) Continuing Operations
99 119 579 87 152 106 453 105 64 77 403
Total Pre-Tax Income
127 159 623 118 153 145 612 146 95 103 538
Total Operating Income
188 221 695 187 183 218 678 209 157 161 599
Total Gross Profit
622 682 1,336 606 626 700 1,302 646 640 658 1,245
Total Revenue
1,559 1,562 2,912 1,384 1,526 1,610 2,787 1,424 1,549 1,594 2,724
Operating Revenue
1,559 1,562 2,912 1,384 1,526 1,610 2,787 1,424 1,549 1,594 2,724
Total Cost of Revenue
937 880 1,576 778 900 910 1,485 778 909 936 1,479
Operating Cost of Revenue
937 880 1,576 778 900 910 1,485 778 909 936 1,479
Total Operating Expenses
434 461 641 419 443 482 624 437 483 497 646
Selling, General & Admin Expense
434 461 641 419 443 482 624 437 483 497 646
Total Other Income / (Expense), net
-61 -62 -72 -69 -30 -73 -66 -63 -62 -58 -61
Interest Expense
86 84 86 82 77 77 76 71 68 68 69
Other Income / (Expense), net
25 22 14 13 47 4.00 10 8.00 6.00 10 8.00
Income Tax Expense
28 40 44 31 1.00 39 159 41 31 26 135
Basic Earnings per Share
$0.43 $0.52 $2.55 $0.39 $0.68 $0.49 $2.06 $0.49 $0.31 $0.38 $1.94
Weighted Average Basic Shares Outstanding
227.38M 225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M
Diluted Earnings per Share
$0.43 $0.52 $2.54 $0.38 $0.68 $0.49 $2.06 $0.49 $0.30 $0.37 $1.95
Weighted Average Diluted Shares Outstanding
227.38M 225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M
Weighted Average Basic & Diluted Shares Outstanding
227.38M 225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M

Annual Cash Flow Statements for Bath & Body Works

This table details how cash moves in and out of Bath & Body Works' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Change in Cash & Equivalents
867 -614 -419 -102 86 2,434 -1,954 -747 -148 -410 279
Net Cash From Operating Activities
2,027 1,990 1,406 1,377 1,236 2,039 1,492 1,144 954 886 1,102
Net Cash From Continuing Operating Activities
2,027 1,990 1,406 1,377 1,236 2,039 1,492 1,144 954 886 1,102
Net Income / (Loss) Continuing Operations
1,253 1,158 983 644 -366 844 1,333 800 878 798 649
Consolidated Net Income / (Loss)
1,253 1,158 983 644 -366 844 1,333 800 878 798 649
Depreciation Expense
457 518 571 590 588 521 363 221 269 282 254
Non-Cash Adjustments To Reconcile Net Income
21 16 127 297 1,147 264 241 38 17 11 23
Changes in Operating Assets and Liabilities, net
338 344 -228 -111 -133 410 -445 85 -210 -205 176
Net Cash From Investing Activities
-443 -833 -698 -609 -480 -219 -259 -328 -286 -162 -227
Net Cash From Continuing Investing Activities
-443 -833 -698 -609 -480 -219 -259 -328 -286 -162 -227
Purchase of Property, Plant & Equipment
-727 -990 -707 -629 -458 -228 -270 -328 -298 -226 -237
Sale of Property, Plant & Equipment
196 53 - - - - - - 0.00 0.00 9.00
Sale and/or Maturity of Investments
59 129 - - - - - 0.00 0.00 40 0.00
Other Investing Activities, net
4.00 8.00 9.00 20 -22 9.00 11 0.00 12 24 1.00
Net Cash From Financing Activities
-716 -1,765 -1,127 -872 -666 610 -3,188 -1,562 -815 -1,132 -599
Net Cash From Continuing Financing Activities
-716 -1,765 -1,127 -872 -666 610 -3,188 -1,562 -815 -1,132 -599
Repayment of Debt
-2.00 -751 -592 -255 -326 -200 -1,716 2.00 -459 -521 -9.00
Repurchase of Common Equity
-483 -435 -446 -198 0.00 0.00 -1,964 -1,312 -148 -401 -401
Payment of Dividends
-1,171 -1,268 -686 -666 -332 -83 -120 -186 -182 -177 -167
Other Financing Activities, net
-55 -38 6.00 -17 -20 -57 612 -66 -26 -33 -22
Effect of Exchange Rate Changes
-1.00 -6.00 0.00 2.00 -4.00 4.00 1.00 -1.00 -1.00 -2.00 3.00

Quarterly Cash Flow Statements for Bath & Body Works

This table details how cash moves in and out of Bath & Body Works' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/29/2023 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026
Net Change in Cash & Equivalents
-256 -378 672 -229 -341 -323 483 -38 -272 -128 717
Net Cash From Operating Activities
33 -49 926 76 -46 -99 955 188 -43 80 877
Net Cash From Continuing Operating Activities
33 -49 918 76 -46 -99 955 188 -43 80 877
Net Income / (Loss) Continuing Operations
99 119 579 87 152 106 453 105 64 77 403
Consolidated Net Income / (Loss)
99 119 579 87 152 106 453 105 64 77 403
Depreciation Expense
66 70 70 71 71 69 71 64 64 63 63
Non-Cash Adjustments To Reconcile Net Income
2.00 -1.00 8.00 12 -27 9.00 16 10 8.00 -1.00 6.00
Changes in Operating Assets and Liabilities, net
-134 -237 261 -94 -242 -283 415 9.00 -179 -59 405
Net Cash From Investing Activities
-82 -63 -47 -46 6.00 -74 -48 -39 -56 -72 -60
Net Cash From Continuing Investing Activities
-82 -63 -47 -46 6.00 -74 -48 -39 -56 -72 -60
Purchase of Property, Plant & Equipment
-85 -72 -48 -46 -55 -65 -60 -37 -56 -81 -63
Other Investing Activities, net
3.00 9.00 1.00 0.00 11 1.00 12 -2.00 - - 3.00
Net Cash From Financing Activities
-208 -266 -206 -259 -301 -150 -422 -188 -174 -135 -102
Net Cash From Continuing Financing Activities
-208 -266 -206 -259 -301 -150 -422 -188 -174 -135 -102
Repayment of Debt
-113 -169 -93 -111 -96 -4.00 -308 -5.00 -10 7.00 -1.00
Repurchase of Common Equity
-48 -51 -49 -96 -152 -101 -52 -136 -118 -90 -57
Payment of Dividends
-46 -45 -45 -45 -45 -44 -43 -43 -42 -41 -41
Other Financing Activities, net
-1.00 -1.00 -19 -7.00 -8.00 -1.00 -19 -4.00 -4.00 -11 -3.00
Effect of Exchange Rate Changes
- - - 0.00 - - - 1.00 1.00 -1.00 2.00

Annual Balance Sheets for Bath & Body Works

This table presents Bath & Body Works' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Total Assets
8,493 8,170 8,149 8,090 10,125 11,571 6,026 5,494 5,463 4,872 5,069
Total Current Assets
4,156 3,465 3,293 3,260 3,245 5,579 3,009 2,266 2,115 1,823 2,019
Cash & Equivalents
2,548 1,934 1,515 1,413 1,499 3,568 1,979 1,232 1,084 674 953
Accounts Receivable
261 294 310 367 306 148 240 226 224 205 180
Inventories, net
1,122 1,096 1,240 1,248 1,287 572 709 709 710 734 699
Other Current Assets
225 141 228 232 153 52 81 99 97 114 106
Other Current Nonoperating Assets
- - - - - 1,239 - - 0.00 96 81
Plant, Property, & Equipment, net
2,330 2,741 2,893 2,818 2,486 1,017 1,009 1,193 1,220 1,127 1,127
Total Noncurrent Assets
2,007 1,964 1,963 2,012 4,394 4,975 2,008 2,035 2,128 1,922 1,923
Goodwill
1,318 1,348 1,348 1,348 628 628 628 628 628 628 628
Intangible Assets
411 411 411 411 411 165 165 165 165 165 165
Noncurrent Deferred & Refundable Income Taxes
30 19 14 62 84 58 45 37 144 130 112
Other Noncurrent Operating Assets
248 186 190 191 3,271 1,143 1,170 1,205 1,191 999 1,018
Total Liabilities & Shareholders' Equity
8,493 8,170 8,149 8,090 10,125 11,571 6,026 5,494 5,463 4,872 5,069
Total Liabilities
8,751 8,897 8,900 8,955 11,620 12,232 7,543 7,699 7,089 6,255 6,348
Total Current Liabilities
1,875 2,014 2,031 1,986 2,372 2,826 1,290 1,379 1,289 1,231 1,591
Short-Term Debt
6.00 36 87 72 61 - - - - 0.00 280
Accounts Payable
668 683 717 711 647 345 435 455 380 338 465
Accrued Expenses
977 997 1,029 1,082 1,052 727 651 673 608 584 579
Current Deferred & Payable Income Tax Liabilities
224 298 198 121 134 83 34 74 120 117 72
Other Current Liabilities
- - - - 478 173 170 177 181 192 195
Total Noncurrent Liabilities
6,876 6,883 6,869 6,969 9,248 9,406 6,253 6,320 5,800 5,024 4,757
Long-Term Debt
5,715 5,700 5,707 5,739 5,487 6,366 4,854 4,862 4,388 3,884 3,612
Noncurrent Deferred & Payable Income Tax Liabilities
257 352 238 226 219 141 157 168 147 24 65
Other Noncurrent Operating Liabilities
904 831 924 1,004 3,542 1,232 1,242 1,290 1,265 1,116 1,080
Total Equity & Noncontrolling Interests
-258 -727 -751 -865 -1,495 -661 -1,517 -2,205 -1,626 -1,383 -1,279
Total Preferred & Common Equity
-259 -729 -753 -869 -1,499 -662 -1,518 -2,206 -1,627 -1,385 -1,281
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-259 -729 -753 -869 -1,499 -662 -1,518 -2,206 -1,627 -1,385 -1,281
Common Stock
701 807 819 912 989 1,034 1,027 939 958 944 902
Retained Earnings
315 205 -1,434 -1,482 -2,182 -1,421 -1,803 -2,401 -1,838 -1,578 -1,435
Treasury Stock
-1,315 -1,753 -162 -358 -358 -358 -822 -822 -822 -822 -822
Accumulated Other Comprehensive Income / (Loss)
40 12 24 59 52 83 80 78 75 71 74
Noncontrolling Interest
1.00 2.00 2.00 4.00 4.00 1.00 1.00 1.00 1.00 2.00 2.00

Quarterly Balance Sheets for Bath & Body Works

This table presents Bath & Body Works' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 4/29/2023 7/29/2023 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025
Total Assets
5,363 5,195 5,243 5,463 5,221 4,948 4,984 4,872 4,881 4,814 4,989
Total Current Assets
2,080 1,893 1,959 2,115 1,917 1,666 1,720 1,823 1,820 1,706 1,881
Cash & Equivalents
1,046 790 412 1,084 855 514 191 674 636 364 236
Accounts Receivable
145 153 197 224 121 146 200 205 103 131 169
Inventories, net
771 818 1,205 710 814 863 1,178 734 869 977 1,251
Other Current Assets
118 132 145 97 127 143 151 114 115 153 144
Other Current Nonoperating Assets
- - - 0.00 0.00 0.00 0.00 96 97 81 81
Plant, Property, & Equipment, net
1,223 1,236 1,244 1,220 1,183 1,166 1,158 1,127 1,111 1,124 1,142
Total Noncurrent Assets
2,060 2,066 2,040 2,128 2,121 2,116 2,106 1,922 1,950 1,984 1,966
Goodwill
628 628 628 628 628 628 628 628 628 628 628
Intangible Assets
165 165 165 165 165 165 165 165 165 165 165
Noncurrent Deferred & Refundable Income Taxes
37 38 35 144 143 143 143 130 133 133 132
Other Noncurrent Operating Assets
1,230 1,235 1,212 1,191 1,185 1,180 1,170 999 1,024 1,058 1,041
Total Liabilities & Shareholders' Equity
5,363 5,195 5,243 5,463 5,221 4,948 4,984 4,872 4,881 4,814 4,989
Total Liabilities
7,533 7,349 7,367 7,089 6,897 6,666 6,732 6,255 6,331 6,361 6,581
Total Current Liabilities
1,277 1,213 1,409 1,289 1,221 1,497 1,575 1,231 1,294 1,303 1,553
Short-Term Debt
- 0.00 0.00 - - 313 314 - - 0.00 0.00
Accounts Payable
426 508 627 380 403 411 510 338 452 567 781
Accrued Expenses
585 518 590 608 489 526 547 584 495 541 558
Current Deferred & Payable Income Tax Liabilities
101 0.00 0.00 120 143 61 16 117 146 1.00 21
Other Current Liabilities
165 187 192 181 186 186 188 192 201 194 193
Total Noncurrent Liabilities
6,256 6,136 5,958 5,800 5,676 5,169 5,157 5,024 5,037 5,058 5,028
Long-Term Debt
4,781 4,668 4,497 4,388 4,282 3,881 3,883 3,884 3,886 3,888 3,890
Noncurrent Deferred & Payable Income Tax Liabilities
168 168 167 147 147 45 45 24 23 23 23
Other Noncurrent Operating Liabilities
1,307 1,300 1,294 1,265 1,247 1,243 1,229 1,116 1,128 1,147 1,115
Total Equity & Noncontrolling Interests
-2,170 -2,154 -2,124 -1,626 -1,676 -1,718 -1,748 -1,383 -1,450 -1,547 -1,592
Total Preferred & Common Equity
-2,171 -2,155 -2,125 -1,627 -1,677 -1,719 -1,749 -1,385 -1,451 -1,548 -1,593
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-2,171 -2,155 -2,125 -1,627 -1,677 -1,719 -1,749 -1,385 -1,451 -1,548 -1,593
Common Stock
940 948 951 958 960 947 942 944 931 917 910
Retained Earnings
-2,366 -2,358 -2,329 -1,838 -1,889 -1,918 -1,942 -1,578 -1,633 -1,716 -1,754
Treasury Stock
-822 -822 -822 -822 -822 -822 -822 -822 -822 -822 -822
Accumulated Other Comprehensive Income / (Loss)
77 77 75 75 74 74 73 71 73 73 73
Noncontrolling Interest
1.00 1.00 1.00 1.00 1.00 1.00 1.00 2.00 1.00 1.00 1.00

Annual Metrics And Ratios for Bath & Body Works

This table displays calculated financial ratios and metrics derived from Bath & Body Works' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
DEI Shares Outstanding
- - - - - - - - - - 204,721,605.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 204,721,605.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 3.17
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
1,420 1,368 1,295 930 787 1,237 1,518 1,045 1,105 983 829
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 39.35% 40.01% 39.29% 31.71%
Earnings before Interest and Taxes (EBIT)
2,268 2,090 1,718 1,242 978 1,554 1,811 1,393 1,366 1,340 1,158
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,683 2,562 2,242 1,789 1,566 2,075 2,174 1,614 1,635 1,622 1,412
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,565 1,208 842 925 1,766 2,709 1,242 978 852 930 981
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,915 3,075 3,528 3,533 2,554 1,082 1,358 1,425 1,678 1,731 1,579
Increase / (Decrease) in Invested Capital
-145 160 453 5.00 -979 -1,472 276 67 253 53 -152
Book Value per Share
($0.89) ($2.55) ($2.67) ($3.16) ($5.42) ($2.38) ($5.89) ($9.66) ($7.20) ($6.39) ($6.26)
Tangible Book Value per Share
($6.87) ($8.70) ($8.90) ($9.55) ($9.18) ($5.23) ($8.97) ($13.13) ($10.71) ($10.06) ($10.13)
Total Capital
5,463 5,009 5,043 4,946 4,053 5,705 3,337 2,657 2,762 2,501 2,613
Total Debt
5,721 5,736 5,794 5,811 5,548 6,366 4,854 4,862 4,388 3,884 3,892
Total Long-Term Debt
5,715 5,700 5,707 5,739 5,487 6,366 4,854 4,862 4,388 3,884 3,612
Net Debt
3,173 3,802 4,279 4,398 4,049 2,798 2,875 3,630 3,304 3,210 2,939
Capital Expenditures (CapEx)
531 937 707 629 458 228 270 328 298 226 228
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-261 -447 -166 -67 -565 -815 -260 -345 -258 -82 -245
Debt-free Net Working Capital (DFNWC)
2,287 1,487 1,349 1,346 934 2,753 1,719 887 826 592 708
Net Working Capital (NWC)
2,281 1,451 1,262 1,274 873 2,753 1,719 887 826 592 428
Net Nonoperating Expense (NNE)
167 210 312 286 1,153 393 185 245 227 185 180
Net Nonoperating Obligations (NNO)
3,173 3,802 4,279 4,398 4,049 1,743 2,875 3,630 3,304 3,114 2,858
Total Depreciation and Amortization (D&A)
415 472 524 547 588 521 363 221 269 282 254
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $1.86 ($1.06) $2.43 $4.96 $0.00 $3.86 $3.62 $3.12
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 344.08M 345.75M 697.21M 238.91M 0.00 224.90M 214.23M 201.13M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $1.85 ($1.06) $2.40 $4.88 $0.00 $3.84 $3.61 $3.11
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 344.08M 345.75M 697.21M 238.91M 0.00 224.90M 214.23M 201.13M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 344.08M 345.75M 697.21M 238.91M 0.00 224.90M 214.23M 201.13M
Normalized Net Operating Profit after Tax (NOPAT)
1,420 1,368 1,295 1,004 787 1,237 1,518 1,045 1,105 983 829
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for Bath & Body Works

This table displays calculated financial ratios and metrics derived from Bath & Body Works' official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/29/2023 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026
DEI Shares Outstanding
- - - - - - - - - - 204,721,605.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 204,721,605.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.97
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
147 165 646 138 182 159 502 150 106 120 449
Return On Investment Capital (ROIC_SIMPLE)
- - 23.39% - - - 20.07% 6.17% 4.52% 5.24% 17.17%
Earnings before Interest and Taxes (EBIT)
213 243 709 200 230 222 688 217 163 171 607
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
279 313 779 271 301 291 759 281 227 234 670
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
167 161 393 -48 -56 -138 449 198 172 397 601
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,724 1,961 1,678 1,751 1,962 2,258 1,731 1,703 1,896 1,981 1,579
Increase / (Decrease) in Invested Capital
-20 4.00 253 186 238 297 53 -48 -66 -277 -152
Book Value per Share
($9.41) ($9.35) ($7.20) ($7.46) ($7.70) ($7.98) ($6.39) ($6.77) ($7.32) ($7.73) ($6.26)
Tangible Book Value per Share
($12.88) ($12.83) ($10.71) ($10.98) ($11.25) ($11.60) ($10.06) ($10.47) ($11.06) ($11.57) ($10.13)
Total Capital
2,514 2,373 2,762 2,606 2,476 2,449 2,501 2,436 2,341 2,298 2,613
Total Debt
4,668 4,497 4,388 4,282 4,194 4,197 3,884 3,886 3,888 3,890 3,892
Total Long-Term Debt
4,668 4,497 4,388 4,282 3,881 3,883 3,884 3,886 3,888 3,890 3,612
Net Debt
3,878 4,085 3,304 3,427 3,680 4,006 3,210 3,250 3,524 3,654 2,939
Capital Expenditures (CapEx)
85 72 48 46 55 65 60 37 56 81 63
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-110 138 -258 -159 -32 268 -82 -110 39 92 -245
Debt-free Net Working Capital (DFNWC)
680 550 826 696 482 459 592 526 403 328 708
Net Working Capital (NWC)
680 550 826 696 169 145 592 526 403 328 428
Net Nonoperating Expense (NNE)
48 46 67 51 30 53 49 45 42 43 46
Net Nonoperating Obligations (NNO)
3,878 4,085 3,304 3,427 3,680 4,006 3,114 3,153 3,443 3,573 2,858
Total Depreciation and Amortization (D&A)
66 70 70 71 71 69 71 64 64 63 63
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.43 $0.52 $2.55 $0.39 $0.68 $0.49 $2.06 $0.49 $0.31 $0.38 $1.94
Adjusted Weighted Average Basic Shares Outstanding
227.38M 225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M
Adjusted Diluted Earnings per Share
$0.43 $0.52 $2.54 $0.38 $0.68 $0.49 $2.06 $0.49 $0.30 $0.37 $1.95
Adjusted Weighted Average Diluted Shares Outstanding
227.38M 225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
227.38M 225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M
Normalized Net Operating Profit after Tax (NOPAT)
147 165 646 138 182 159 502 150 106 120 449
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Financials Breakdown Chart

Key Financial Trends

Bath & Body Works (NYSE: BBWI) released quarterly results across 2022–2025 in a way that highlights a mix of improving cash flow, margin stability, and ongoing leverage concerns. Below are the 10 most important takeaways, focusing on the latest Q4 2025 results and the four-year trend.

  • Q4 2025 net cash from continuing operating activities was around $877 million, signaling strong quarterly operating cash flow that supports liquidity as the company navigates investment needs.
  • Gross margin in Q4 2025 was about 45.7% (gross profit of roughly $1.245B on $2.724B revenue), a stable level in the mid-40s and modestly higher than Q4 2024’s margin around 45.1%.
  • Q4 2025 net income attributable to common shareholders was about $403 million, showing continued quarterly profitability despite a year-over-year revenue decline.
  • The company posted a substantial positive net change in cash of about $717 million in Q4 2025, contributing to a stronger near-term liquidity position.
  • Weighted average basic shares outstanding declined modestly in Q4 2025 (around 201.1 million), which can help per-share metrics and EPS in a given quarter.
  • Dividends per share remained at $0.20, indicating a steady shareholder payout policy even as leverage and working capital dynamics evolve.
  • Capital expenditure remained modest in Q4 2025 (PPE purchases near $63 million) with investing cash flow around -$60 million, implying ongoing but controlled capital spending.
  • Revenue declined year-over-year in Q4 2025 to about $2.724 billion from $2.888 billion in Q4 2024, illustrating continued top-line pressure despite margin stability.
  • Net income declined year-over-year in Q4 2025 (403M vs 453M in Q4 2024), signaling softer earnings despite a profitable quarter.
  • The balance sheet shows persistent high leverage: long-term debt near $3.88 billion and negative equity around -$1.59 billion, with total liabilities around $6.58 billion in Q3 2025, highlighting structural leverage risks.
05/06/26 07:50 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Bath & Body Works' Financials

When does Bath & Body Works' fiscal year end?

According to the most recent income statement we have on file, Bath & Body Works' financial year ends in January. Their financial year 2026 ended on January 31, 2026.

How has Bath & Body Works' net income changed over the last 10 years?

Bath & Body Works' net income appears to be on a downward trend, with a most recent value of $649 million in 2025, falling from $1.25 billion in 2015. The previous period was $798 million in 2024. View Bath & Body Works' forecast to see where analysts expect Bath & Body Works to go next.

What is Bath & Body Works' operating income?
Bath & Body Works' total operating income in 2025 was $1.13 billion, based on the following breakdown:
  • Total Gross Profit: $3.19 billion
  • Total Operating Expenses: $2.06 billion
How has Bath & Body Works' revenue changed over the last 10 years?

Over the last 10 years, Bath & Body Works' total revenue changed from $12.15 billion in 2015 to $7.29 billion in 2025, a change of -40.0%.

How much debt does Bath & Body Works have?

Bath & Body Works' total liabilities were at $6.35 billion at the end of 2025, a 1.5% increase from 2024, and a 27.5% decrease since 2015.

How much cash does Bath & Body Works have?

In the past 10 years, Bath & Body Works' cash and equivalents has ranged from $674 million in 2024 to $3.57 billion in 2020, and is currently $953 million as of their latest financial filing in 2025.

How has Bath & Body Works' book value per share changed over the last 10 years?

Over the last 10 years, Bath & Body Works' book value per share changed from -0.89 in 2015 to -6.26 in 2025, a change of 599.3%.



Financial statements for NYSE:BBWI last updated on 3/14/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners